eHealth Director Receives 34,574 RSUs in Annual Stock Compensation Grant

eHealth (EHTH) Director Prama Bhatt received an annual equity grant of 34,574 restricted stock units (RSUs) on June 17, 2025, as part of the company's non-employee director compensation program.

Rhea-AI Filing Summary

eHealth (EHTH) Director Prama Bhatt received an annual equity grant of 34,574 restricted stock units (RSUs) on June 17, 2025, as part of the company's non-employee director compensation program. The RSUs were granted at $0 cost and increased Bhatt's total beneficial ownership to 79,438 shares.

Key terms of the RSU grant:

• Vesting occurs in four equal quarterly installments starting June 17, 2025
• Full vesting acceleration triggers: - Day before next annual stockholder meeting - Upon Change in Control
• Vesting contingent on continued service as defined in the 2024 Equity Incentive Plan

This Form 4 filing was submitted by attorney-in-fact Sonwha Lee on June 20, 2025, within the required reporting timeline for insider transactions.

Insider Trade Summary

Grant/Award: 34,574 shares

Grant/Award 1 txn

Insider Bhatt Prama

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	34,574	$0.00	$0.00

Holdings After Transaction: Common Stock — 79,438 shares (Direct)

Footnotes (1)

1. F1. This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 17, 2025, subject to the individual's continued status as a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EHTH shares did Director Prama Bhatt acquire on June 17, 2025?

Director Prama Bhatt acquired 34,574 restricted stock units (RSUs) of EHTH on June 17, 2025, as part of the annual award to non-employee directors. Each RSU represents a right to receive one share of eHealth's common stock upon vesting.

What is the vesting schedule for EHTH Director Bhatt's RSU grant?

The RSUs vest in four equal quarterly installments starting from June 17, 2025. However, any unvested RSUs will fully vest either (1) the day before eHealth's next annual stockholder meeting or (2) if the company undergoes a Change in Control, subject to continued service as a director.

How many EHTH shares does Prama Bhatt own after the June 17, 2025 RSU grant?

Following the RSU grant transaction, Prama Bhatt beneficially owns 79,438 shares of EHTH common stock directly (indicated as ownership form 'D' in the filing).

What was the purchase price of EHTH RSUs granted to Director Bhatt?

The RSUs were granted at $0 cost to Director Bhatt, as they were part of the annual equity compensation for non-employee directors under eHealth's 2024 Equity Incentive Plan.

When did EHTH Director Prama Bhatt file this Form 4?

The Form 4 was filed on June 20, 2025, within the required reporting window, as evidenced by the signature date on the filing. The reported transaction occurred on June 17, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/20/2025 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bhatt Prama

(Last) (First) (Middle)

C/O EHEALTH, INC.

13620 RANCH ROAD 620 N, SUITE A250

(Street)

AUSTIN TX 78717

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
eHealth, Inc. [ EHTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2025		A		34,574(1)	A	$0	79,438	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 17, 2025, subject to the individual's continued status as a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date.

Remarks:

	/s/ Sonwha Lee, as attorney-in-fact for Prama Bhatt	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.